

Oraya Therapeutics develops non-invasive robotically-controlled treatments for inflammatory and neovascular diseases of the eye. Among its major competitors, Oraya Therapeutics is ranked in 4th place for NPS while Genentech is 1st, and Pulsar Vascular is 2nd.